← Back to headlines
US Withdraws Pancreatic Cancer Study by Barbacid Due to Conflict of Interest
A study on pancreatic cancer by Barbacid and two co-authors has been withdrawn by a US academy due to a conflict of interest. The researchers reportedly have financial interests in Vega Oncotargets, a company established to develop therapies for this type of cancer.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
